GC
LSTA icon

Guggenheim Capital’s Lisata Therapeutics LSTA Stock Holding History

Guggenheim Capital’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-79
Closed -$30K – 3072
2015
Q1 		$30K Buy
79
+9
+13% +$4.88K ﹤0.01% 2972
2014
Q4 		$40K Buy
+70
New +$47.6K ﹤0.01% 2936
2014
Q3 		– Sell
-96
Closed -$93K – 3067
2014
Q2 		$93K Buy
96
+15
+19% +$14.6K ﹤0.01% 3018
2014
Q1 		$86K Buy
+81
New +$87.8K ﹤0.01% 3052
2013
Q3 		– Sell
-34
Closed -$29K – 3137
2013
Q2 		$29K Buy
+34
New +$29.8K ﹤0.01% 2955

Other funds holding LSTA

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Guggenheim Capital's LSTA Position: Q2 2015 in Review

Guggenheim Capital sold out of Lisata Therapeutics (LSTA) in Q2 2015, closing a stake of 79 shares — an estimated $30K sold.

Guggenheim Capital first reported a position in LSTA in Q2 2013 and held it in 5 quarters. The position peaked at $93K in Q2 2014. 51 funds tracked by Wall St. Rank hold LSTA as of Q2 2015.

  • Guggenheim Capital reported no remaining Lisata Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Guggenheim Capital sold 79 Lisata Therapeutics shares in Q2 2015, an estimated $30K.
  • Guggenheim Capital first reported a position in Lisata Therapeutics in Q2 2013 and held it in 5 quarters.
  • Guggenheim Capital's Lisata Therapeutics position peaked at $93K in Q2 2014.
  • 51 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2015.

Based on Guggenheim Capital's 13F filing for Q2 2015, filed 14 Aug 2015.